Biggest News Aggregation in the World
📰 Mol Ther News

Mol Ther News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Mol Ther. Real-time updates on events, politics, business and more.

Frontiers | Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection

1 Abstract The devastating Ebola outbreak in West Africa in 2013-2016 accelerated the progress of several medical countermeasures (MCMs) against Ebola virus disease (EVD). Several IPs were used during that outbreak, but no conclusion on efficacy could be drawn. Only the Randomized Controlled Trial (RCT) on ZMapp was promising but inconclusive. More recently, during the second largest Ebola outbreak in North Kivu and Ituri provinces, Democratic Republic of the Congo (DRC), four IPs (Remdesivir, R...
Democratic Republic Of The Congo Democratic Republic Of The General Bas Congo Virion Glycoproteins Nat Microbiol Ridgeback Biotherapeutics

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Moving Forward after Two Deaths in a Gene Therapy Trial of Myotubular Myopathy

Moving Forward after Two Deaths in a Gene Therapy Trial of Myotubular Myopathy 1 The sponsor of this clinical study, Audentes Therapeutics (which was acquired by Japan’s Astellas Pharma in 2019), had generated impressive efficacy studies in a canine model of MTM 2 and conducted non-primate (NHP) safety studies before advancing into the clinic. 3 The initial cohort of six pediatric MTM patients dosed at 1×10 14 genome copies (GC)/kg also showed encouraging results. However, all three patien...
United States Astellas Pharma Jesse Gelsinger American Society For Gene Dose Intravenous Administration Disease Community

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science